Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 22, Issue 21, 2008, Pages 3401-3409

  Huang, Yong ^a   Gandhi, Monica ^b   Greenblatt, Ruth M ^a,b   Gee, Winnie ^a   Lin, Emil T ^a   Messenkoff, Nicholas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; DRUG PRODUCTS; ELECTROSPRAY IONIZATION; EXTRACTION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

ANTI-HIV; ANTIRETROVIRALS; COEFFICIENTS OF VARIATIONS; CONTROL SAMPLES; EFAVIRENZ; HUMAN HAIR; LC-MS-MS; LIQUID CHROMATOGRAPHY COUPLED WITH TANDEM MASS SPECTROMETRIES; LOPINAVIR; SENSITIVE ANALYSIS;

QUALITY CONTROL;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BENZOXAZINE DERIVATIVE; EFAVIRENZ; LOPINAVIR; PYRIMIDINONE DERIVATIVE; RITONAVIR;

ARTICLE; CASE CONTROL STUDY; CHEMISTRY; DOSE RESPONSE; ELECTROSPRAY MASS SPECTROMETRY; HAIR; HUMAN; LIQUID CHROMATOGRAPHY; METHODOLOGY; QUALITY CONTROL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOLUTION AND SOLUBILITY; STANDARD; TANDEM MASS SPECTROMETRY;

ANTI-HIV AGENTS; BENZOXAZINES; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; HAIR; HUMANS; PYRIMIDINONES; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RITONAVIR; SENSITIVITY AND SPECIFICITY; SOLUTIONS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 58149265518     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.3750     Document Type: Article

References (20)

1. Back D, Gibbons S, Khoo S. Ther. Drug Monit. 2006; 28: 468.
2. Khoo SH, Lloyd J, Dalton M, et al. J. Acquir. Immune Defic. Syndr. 2006; 41: 461.
3. Vanhove GF, Schapiro JM, Winters MA, et al. J. Am. Med. Assn. 1996; 276: 1955.
4. Condra JH, Schleif WA, Blahy OM, et al. Nature 1995; 374: 569.
5. Burger DM, Hugen PW, Aarnoutse RE, et al. Ther. Drug Monit. 2003; 25: 73.
6. Clevenbergh P, Garraffo R, Durant J, et al. AIDS 2002; 16: 2311.
7. Nettles RE, Kieffer TL, Parsons T, et al. Clin. Infect. Dis. 2006; 42: 1189.
8. Gandhi M, Greenblatt RM. Ann. Intern. Med. 2002; 137: 696.
9. Nakahara Y. J. Chromatogr. B. Biomed. Sci. Appl. 1999; 733: 161.
10. Uematsu T. Clin. Pharmacokin. 1993; 25: 83.
11. Beumer JH, Bosman IJ, Maes RA. Int. J. Clin. Pract. 2001; 55: 353.
12. Bernard L, Vuagnat A, Peytavin G, et al. Ann. Intern. Med. 2002; 137: 656.
13. Servais J, Peytavin G, Arendt V, et al. AIDS 2001; 15: 941.
14. Duval X, Peytavin G, Breton G, et al. AIDS 2007; 21: 106.
15. Viswanathan CT, Bansal S, Booth B, et al. AAPS J. 2007; 9: E30.
16. Alexander CS, Montaner JS, Asselin JJ, et al. Ther. Drug Monit. 2004; 26: 516.
17. Jurado C, Sachs H. Forensic Sci. Int. 2003; 133: 175.
18. Maurin MB, Rowe SM, Blom K, et al. Pharm. Res. 2002; 19: 517.
19. Gandhi M, Ameli N, Bacchetti P, et al. Concentrations of lopinavir and ritonavir in hair are strongly correlated with virologic success. Proc. 14th Conf. Retroviral and Opportunistic Infections, Los Angeles, California, 2007.
20. Gandhi M, Niloufar A, Bacchetti P, et al. Lancet 2008; manuscript submitted.